Xvivo Perfusion AB (XVIPF)
25.48
-5.47
(-17.67%)
USD |
OTCM |
Sep 17, 16:00
Xvivo Perfusion Price : 25.48 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 25.67 | 25.67 | 25.48 | 25.48 | 1100.00 |
| Sep 16, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 15, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 14, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 11, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 10, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 09, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 08, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 04, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 03, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 02, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Sep 01, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 31, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 28, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 27, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 26, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 25, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 24, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 21, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 20, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 16.00 |
| Aug 19, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 18, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 0.000 |
| Aug 17, 2026 | 30.95 | 30.95 | 30.95 | 30.95 | 100.00 |
| Aug 14, 2026 | 30.00 | 30.00 | 30.00 | 30.00 | 0.000 |
| Aug 13, 2026 | 30.00 | 30.00 | 30.00 | 30.00 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Getinge AB | 24.24 |
| Paxman AB | 3.50 |
| Enovis Corp. | 17.65 |
| Edwards Lifesciences Corp. | 88.09 |
| Intuitive Surgical, Inc. | 392.06 |
Price Related Metrics
| PE Ratio | 84.34 |
| PS Ratio | 8.391 |
| Price to Book Value | 3.530 |
| Price to Free Cash Flow | 31.94 |
| Earnings Yield | 1.19% |
| Market Cap | 802.61M |
| Operating PE Ratio | 68.98 |
| Normalized PE Ratio | 84.54 |